Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.54 +1.71 (+2.32%)
As of: Nov 11, 2026 · 12:13 PM EST

Tarsus Pharmaceuticals (TARS) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Depreciation & Amortization (CF) of $800,000 for Q3 2026, up 300.0% from $200,000 a year earlier and unchanged from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Tarsus Pharmaceuticals' Depreciation & Amortization (CF) came in at $2 million, up 143.9% year-over-year; for FY2025, it was $900,000, up 28.6% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 56.5% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $700,000 in FY2024 (-5.9%), $744,000 in FY2023 (+128.9%), $325,000 in FY2022 (+4.2%) and $312,000 in FY2021 (+225.0%).
  • Year over year, Depreciation & Amortization (CF) gained in four of the last eight quarters, with growth averaging 85.4%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2026 (growth of 300.0%); the low point was Q2 2024 (a decline of 45.1%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $800,000 (Q2 2026), $200,000 (Q1 2026) and $200,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn 800,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 800,000.00
Jun 30, 2026 800,000.00
Mar 31, 2026 200,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 220,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 244,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 182,000.00
Mar 31, 2023 104,000.00
Dec 31, 2022 98,000.00
Sep 30, 2022 94,000.00
Jun 30, 2022 92,000.00
Mar 31, 2022 41,000.00
Dec 31, 2021 40,000.00
API Access

Tarsus Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TARS&period=max&api_key=YOUR_API_KEY